Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

Seohyuk Lee et al, Adjuvant aspirin therapy and colorectal cancer survival, The Lancet Gastroenterology & Hepatology (2025). DOI: 10.1016/S2468-1253(24)00393-5 Journal information: The Lancet ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations ...

Opens in a new tab or window Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly improve disease-free survival (DFS ...

In one trial, 635 patients with previously resected colorectal cancer received daily aspirin (325 mg) or placebo. During an average follow-up of 31 months (during which most patients underwent 1 ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of ...

Opens in a new tab or window SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) recurrence, according to ...

"Knowing whether taking a low-dose aspirin daily is advisable or not for you is vital health information," she added. Related ...